NL-OMON20879尚未招募不适用
Percutaneous Coronary Intervention before TAVI trial
ot applicable (funding by ZonMW)0 个研究点目标入组 466 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 466
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion Criteria:
- •1. Symptomatic severe aortic valve stenosis meeting the criteria stated by the ESC;
- •2. TAVI recommended by multidisciplinary Heart Team;
- •3. Significant coronary artery disease: = 1 stenosis in epicardial coronary artery (> 2.5mm) or bypass graft. Stenosis is considered significant if angiographic 70-99% or angiographic 40-70% with positive hemodynamic parameters
排除标准
- •1. LM-stenosis or equivalent
- •2. CAD with patent bypass grafts
- •3. Contraindication for DAPT
- •4. Life expectancy < 1 year
研究者
相似试验
进行中（未招募）
不适用
Percutaneous Coronary Intervention Before Transcatheter Aortic Valve ImplantationValvular Heart DiseaseAortic Valve StenosisCoronary Artery DiseaseNCT05078619UMC Utrecht466
招募中
不适用
The TAVI PCI (optimal timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention) TrialNL-OMON51090Academisch Medisch Centrum100
招募中
4 期
PeRcutaneous cOronary intervention before Transcatheter Aortic Valve Implantation trialCoronary artery disease / Aortic valve stenosis10011082NL-OMON56109niversitair Medisch Centrum Utrecht466
已完成
4 期
Randomized Trial of Immediate Versus Early and Selective Invasive Percutaneous Coronary Intervention in NSTEMIMyocardial InfarctionNCT00402675University of Leipzig600
已完成
不适用
Post-TAVI Coronary Access StudyTranscatheter Aortic Valve ReplacementNCT04649190Sheba Medical Center200